This week we’re podcasting from the International Society for Bipolar Disorders 2020 conference, where we’ve been scouring the virtual halls for all that is practical and newsworthy. The yield is high so tune in for a new episode every day. Today, unpublished findings on the first solo psychotherapy study in...

This week we’re podcasting from the International Society for Bipolar Disorders 2020 conference, where we’ve been scouring the virtual halls for all that is practical and newsworthy. The yield is high so tune in for a new episode every day. Today, new results on an anti-inflammatory medication in bipolar depression.Published...

The first clinical trial of a modified diet for bipolar disorder in this daily dispatch from the International Society for Bipolar Disorders 2020 conference.Published On: 6/30/2020Duration: 7 minutes, 50 secondsTranscript: This week we’re podcasting DAILY from the International Society for Bipolar Disorders 2020 conference, where we’ve been scouring the virtual halls...

Daily dispatches from the International Bipolar Disorders Conference. There are four atypical antipsychotics that treat bipolar depression, but which have the best balance of efficacy and tolerability?Published On: 6/29/2020Duration: 5 minutes, 15 secondsTranscript:Will the Best Atypical Stand Up?This week we’re podcasting from the International Society for Bipolar Disorders 2020 conference,...

Lemborexant/Dayvigo is the second in sleep med to join the orexin receptor antagonist family. It’s now on the pharmacy shelves, where it sits beside Suvorexant/Bellsomra, released in 2015. Landry I, Nakai K, Ferry J, et al. Pharmacokinetics, pharmacodynamics, and safety of the dual orexin receptor antagonist lemborexant: Findings from single-dose and...

Your patient is experiencing profound grief after the death of his wife. He can’t afford individual therapy and wonders if a support group can help. Will talking about grief to a room of strangers just trigger him more, or will it help? This metanalysis of 14 randomized controlled trials has...

Evening light is associated with so many health risks ─ cancer, diabetes, heart disease ─ that the AMA has a position statement on it. Psychiatrists may need to pay attention as well. It’s been linked to depression, mania, and poor cognition in epidemiologic studies, and this animal study confirms that. An...

Lithium, atypical antipsychotics, ketamine, thyroid… these consistently rank among the most effective medications for treatment resistant depression, but which is the strongest? Strawbridge R, Carter B, Marwood L, et al. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis. Br J Psychiatry. 2019;214(1):42‐51. [Link]Published On: 6/24/2020Duration: 2 minutes, 8 secondsTranscript:Lithium, atypical antipsychotics,...

The brain changes that lead to dementia can be seen as early as 25 years before the illness starts. We can’t test for those changes, but who might be at risk? This meta-analysis led by Carol Hudon looked at studies that followed healthy middle aged adults with no cognitive problems...

Don't have a DBT center near you? Dr. Lois Choi-Khan has developed a new form of psychotherapy that may work almost as well. In this interview she shares her top tips from this pragmatic approach called Good Psychiatric Management. Featuring archival audio from the late John Gunderson courtesy of borderlinethefilm.com.Published On: 6/22/20Duration:...